Notice published on March 27 by Justice Department

The US Justice Department published a one page notice on March 27, according to the U.S. Government Publishing Office.

The notice is focused on Bulk Manufacturer of Controlled Substances Application: Apertus Pharmaceuticals.

The Department is one of the oldest in the US, focused primarily on law enforcement and the federal prison system. Downsizing the Federal Government, a project aimed at lowering taxes and boosting federal efficiency, detailed wasteful expenses such as $16 muffins at conferences and board meetings.

Notices are required documents detailing rules and regulations being proposed by each federal department. This allows the public to see what issues legislators and federal departments are focusing on.

Any person or organization can comment on the proposed rules. Departments and agencies must then address “significant issues raised in comments and discuss any changes made,” the Federal Register says.

Notices published by the Justice Department on March 27

Title
Importer of Controlled Substances Application: HOSPIRA
Importer of Controlled Substances Application: Meda Pharmaceuticals, Inc.
United States and State of New York v. Twin America, LLC, et al.; Proposed Final Judgment and Competitive Impact Statement
Bulk Manufacturer of Controlled Substances Application: Apertus Pharmaceuticals
Agency Information Collection Activities: Proposed eCollection eComments Requested; Licensed Firearms Manufacturers Records of Production, Disposition, and Supporting Data
Agency Information Collection Activities: Proposed eCollection eComments Requested; Firearms Disabilities for Nonimmigrant Aliens
Agency Information Collection Activities: Proposed eCollection eComments Requested; Report of Firearms Transaction-Demand 2
Agency Information Collection Activities: Proposed eCollection eComments Requested; Records of Acquisition and Disposition, Registered Importers of Arms, Ammunition, and Implements of War on the U.S. Munitions Imports List
Notice of Lodging of Proposed Consent Decree Under the Clean Air Act
Importer of Controlled Substances Application: Mylan Pharmaceuticals, Inc.